A. Company Background & History “Galderma is a Swiss pharmaceutical company specializing in the research, development and marketing of therapeutic, corrective and aesthetic solutions for dermatology patients and a leading player in the worldwide dermatology market. Its expertise spans a broad spectrum of skin, hair and nail diseases.”(Wikipedia.com) On 1961, the Owen dermatology company was created in Dallas, Texas, USA. Then on 1972, Alcon, a phthalmology specialist acquired Owe. Then after 5 years, Nestlé acquired Alcon to strengthen its presence in the North American market. Then, L’Oreal created its International Dermatology Research Center (CIRD) in Sophia-Antipolis, France, specializing in fundamental research into skin physiology on 1979. Then finally, Nestlé and L’Oreal form a joint venture to become the world’s leading dermatology player. Thus, Galderma was born. Since the creation of Galderma in 1981 as a joint venture between Nestlé and L’Oreal, all of its resources have been channelled in a single direction: to provide innovative therapeutic, corrective and aesthetic solutions that meet the needs of dermatology patients and physicians. Galderma’s experience has taught it that the effects of skin conditions reach much deeper than the skin itself. By treating these conditions, it helps people improve the quality of their life. It pays special attention not only to the safety and efficacy of its products, but also to the way they can be best administrated by the patients themselves or by medical professionals. This constant search for the best therapeutic and aesthetic results drives its scientists to explore new areas in dermatological innovation. The company’s growing international portfolio includes treatment for major skin conditions – acne, pigmentary disorders, rosacea, psoriasis / SRD (Steroid-Responsive Dermatoses). Galderma is one of the leading dermatology companies worldwide. In 2008,
A. Company Background & History “Galderma is a Swiss pharmaceutical company specializing in the research, development and marketing of therapeutic, corrective and aesthetic solutions for dermatology patients and a leading player in the worldwide dermatology market. Its expertise spans a broad spectrum of skin, hair and nail diseases.”(Wikipedia.com) On 1961, the Owen dermatology company was created in Dallas, Texas, USA. Then on 1972, Alcon, a phthalmology specialist acquired Owe. Then after 5 years, Nestlé acquired Alcon to strengthen its presence in the North American market. Then, L’Oreal created its International Dermatology Research Center (CIRD) in Sophia-Antipolis, France, specializing in fundamental research into skin physiology on 1979. Then finally, Nestlé and L’Oreal form a joint venture to become the world’s leading dermatology player. Thus, Galderma was born. Since the creation of Galderma in 1981 as a joint venture between Nestlé and L’Oreal, all of its resources have been channelled in a single direction: to provide innovative therapeutic, corrective and aesthetic solutions that meet the needs of dermatology patients and physicians. Galderma’s experience has taught it that the effects of skin conditions reach much deeper than the skin itself. By treating these conditions, it helps people improve the quality of their life. It pays special attention not only to the safety and efficacy of its products, but also to the way they can be best administrated by the patients themselves or by medical professionals. This constant search for the best therapeutic and aesthetic results drives its scientists to explore new areas in dermatological innovation. The company’s growing international portfolio includes treatment for major skin conditions – acne, pigmentary disorders, rosacea, psoriasis / SRD (Steroid-Responsive Dermatoses). Galderma is one of the leading dermatology companies worldwide. In 2008,